2nd ARDS Drug Development Summit 2022
Evvnt Promotion / evvnt
13.07.2022 - 15.07.2022 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 09:00 - 16:15
Conference themes
Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data, the 2nd ARDS Drug Development Summit is the only translational conference for drug developers to leverage the large homogeneous populations of COVID ARDS.
Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data, the 2nd ARDS Drug Development Summit is the only translational conference for drug developers to leverage the large homogeneous populations of COVID ARDS.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Speakers: Alistair Wheeler, Chief Medical Officer, BioMarck Pharmaceuticals, Alpha A. Fowler, Professor, Virginia University, Aurelia De Pauw, Senior Vice President - Clinical Programs and Medical Affairs, Tetra Bio-Pharma and more.
Speakers: Alistair Wheeler, Chief Medical Officer, BioMarck Pharmaceuticals, Alpha A. Fowler, Professor, Virginia University, Aurelia De Pauw, Senior Vice President - Clinical Programs and Medical Affairs, Tetra Bio-Pharma and more.
Enquiries and Registration:
https://go.evvnt.com/1034443-1?pid=4832
Ms. Jessica Durston
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
